You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 121 No. 12, December 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinicopathologic Reports, Case Reports, and Small Case Series
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on ISI (2)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Corneal Disorders
 •Alert me on articles by topic

Benign Fibrous Histiocytoma of the Corneoscleral Limbus: Unique Clinicopathologic Features

Arch Ophthalmol. 2003;121:1776-1779.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

A benign fibrous histiocytoma (BFH) involving the limbus is a rare type of tumor. We describe 2 patients with unique clinicopathologic features that, to our knowledge, have not previously been described.

Report of Cases.

Case 1. A 26-year-old white woman was referred to us because of an enlarging mass in the left inferonasal limbus. The lesion had been excised at another institution but recurred 6 weeks postoperatively. On examination, her best-corrected visual acuity was 20/20 OD and 20/60 OS due to irregular astigmatism. The right eye was normal. The left eye revealed a yellow limbal mass between the 7:30 and 10-o'clock meridians, with marked corneal involvement (Figure 1A). Gonioscopy showed no intraocular involvement; however, the lesion reached the deep corneal stroma without breaching the Descemet membrane. The patient was systemically well. A 10-mm-diameter en bloc excision with a tectonic corneoscleral graft was performed. After more than 9 years of follow-up, . . . [Full Text of this Article]


Comment.
R. M. Conway, MD, PhD; Leonard M. Holbach, MD; Gottfried O. H. Naumann, MD
Erlangen, Germany

R. Max Conway, MD, PhD
Sydney, Australia

Corresponding author and reprints: R. M. Conway, MD, PhD, Department of Ophthalmology and Eye Hospital, University Erlangen-Nürnberg, Schwabachanlage 6, D-91054 Erlangen, Germany (e-mail: rmaxconway@hotmail.com).







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.